comparemela.com

Latest Breaking News On - Medivir - Page 6 : comparemela.com

Medivir partners with world-leading liver cancer experts in new Scientific Advisory Council

/PRNewswire/ Medivir AB (Nasdaq: MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high.

Glasgow cityUnited kingdomComunidad autonoma de catalunaJeff evansRichard finnJeong heoMagnus christensenPia baumannMaria reigArndt vogelSchool of cancer sciencesGlasgow experimental cancer medicine centreProfessor of translational cancer researchScotland cancer centreNational clinicalScotland cancer research network

Medivir s patent application for fostrox approved in China

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

United statesMagnus christensenJens lindbergNasdaq stockholmSmall cap

Medivir has completed the dose escalation part (phase 1b) of the 1b/2a study in HCC and focuses on the combination of fostrox and Lenvima

/PRNewswire/ Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

South koreaUnited kingdomPia baumannMagnus christensenNasdaq stockholmSmall cap

Medivir to present at the Redeye Growth Day

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Jens lindbergRichard ramaniusMagnus christensenNasdaq stockholmRedeye growth daySmall cap

Change in the number of shares and votes in Medivir AB (publ)

/PRNewswire/ Medivir AB (publ) ("Medivir") (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during May.

Magnus christensenNasdaq stockholmSwedish financial instruments tradingSmall capHealth care amp hospitalsMedical pharmaceuticalsAccounting news amp issues

vimarsana © 2020. All Rights Reserved.